OrthoPediatrics (NASDAQ: KIDS) and ConforMIS (NASDAQ:CFMS) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, risk, institutional ownership, profitability, analyst recommendations and dividends.


This table compares OrthoPediatrics and ConforMIS’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
OrthoPediatrics N/A N/A N/A
ConforMIS -72.70% -76.88% -51.42%

Analyst Ratings

This is a summary of current ratings for OrthoPediatrics and ConforMIS, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
OrthoPediatrics 0 0 4 0 3.00
ConforMIS 0 3 2 0 2.40

OrthoPediatrics presently has a consensus target price of $23.67, indicating a potential upside of 20.26%. ConforMIS has a consensus target price of $6.13, indicating a potential upside of 102.81%. Given ConforMIS’s higher possible upside, analysts clearly believe ConforMIS is more favorable than OrthoPediatrics.

Institutional and Insider Ownership

36.0% of ConforMIS shares are held by institutional investors. 9.6% of ConforMIS shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Earnings & Valuation

This table compares OrthoPediatrics and ConforMIS’s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
OrthoPediatrics N/A N/A N/A N/A N/A
ConforMIS $79.90 million 1.71 -$57.58 million ($1.34) -2.25

OrthoPediatrics has higher earnings, but lower revenue than ConforMIS.


OrthoPediatrics beats ConforMIS on 5 of the 9 factors compared between the two stocks.

About OrthoPediatrics

OrthoPediatrics Corp. is a United States-based medical device company. The Company designs, develops and commercializes orthopedic implants and instruments to meet the specialized needs of pediatric surgeons and their patients. It operates through the OrthoPediatrics segment, which designs, develops and markets implants and devices for children with orthopedic problems. Its products include RESPONSE Spinal Deformity System, PediNail Intramedullary Nail System, PediLoc Plating Systems, ACL Reconstruction System, Locking Cannulated Blade (LCB) plate system, Locking Proximal Femur (LPF) plate system, PediFlex Flexible Nailing System, PediFrag, PediLoc Extension Osteotomy Plate (PLEO), PediLoc Femur Locking Plate System, PediLoc Tibia Locking Plate System, PediPlates system and Spica Table. It markets over 20 surgical systems that serve approximately three categories within pediatric orthopedic market, including trauma and deformity, complex spine and anterior cruciate ligament reconstruct

About ConforMIS

ConforMIS, Inc. is a medical technology company. The Company uses its iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants, which are individually sized and shaped, to fit each patient’s anatomy. The Company’s iFit technology platform is applicable to various joints. It offers a line of customized knee implants designed to restore the natural shape of a patient’s knee. It offers iTotal CR, which is a total knee replacement implant. Its iFit technology platform consists of three elements, including iFit Design, its algorithms and computer software that is used to design customized implants and associated single-use patient-specific instrumentation referred to as iJigs, based on computed tomography scans of the patient and to prepare a surgical plan customized for the patient (iView); iFit Printing, which is a three-dimensional printing technology used to manufacture iJigs, and iFit Just-in-Time manufacturing and delivery capabilities.

Receive News & Ratings for OrthoPediatrics Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OrthoPediatrics Corp. and related companies with MarketBeat.com's FREE daily email newsletter.